# Zydus MedTech partners with Braile Biomedica for TAVI device rights

Zydus MedTech, a subsidiary of Zydus Lifesciences, has entered a strategic partnership with Brazil-based Braile Biomedica to exclusively commercialize Braile's Transcatheter Aortic Valve Implantation (TAVI) technology in Europe, India, and select markets. The purchase price was not disclosed.

- Type: Contract
- Announced: 2025-04-18
- Status: announced
- Products: Transcatheter Aortic Valve Implantation (TAVI) system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Braile Biomedica](https://endata.com/companies/24974.md) (supplier)
- [Zydus Lifesciences](https://endata.com/companies/83411.md) (partner)
- [Zydus MedTech](https://endata.com/companies/84246.md) (customer)

## Sources

- [health.economictimes.indiatimes.com](https://health.economictimes.indiatimes.com/news/medical-devices/zydus-medtech-bags-global-rights-of-brazilian-aortic-valve-device-boost-cardiac-play/120412825), 2025-04-18: "Zydus MedTech, a wholly owned subsidiary of Indian pharma major Zydus Lifesciences, has obtained commercial rights to an aortic valve device from Brazil-based Braile Biomedica for Europe, India, and other select markets."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.